Angion Biomedica Corp. (ANGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 1.3000 |
| Open | 1.3200 |
| Bid | 1.2600 x 1200 |
| Ask | 1.3800 x 800 |
| Day's range | 1.2600 - 1.3710 |
| 52-week range | 1.2200 - 16.2570 |
| Volume | |
| Avg. volume | 84,161 |
| Market cap | 38.945M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
The Zacks Analyst Blog Highlights Angion Biomedica, Applied Therapeutics, Bolt Biotherapeutics, Ikena Oncology, and Landos Biopharma
Angion Biomedica, Applied Therapeutics, Bolt Biotherapeutics, Ikena Oncology, and Landos Biopharma are part of Zacks top Analyst Blog
- Zacks
5 Biotech Stocks Set to Outpace Q1 Earnings Estimates
Let us take a look at some drug/biotech stocks, ANGN, APLT, BOLT, IKNA and LABP, which are poised to beat on first-quarter earnings.
- Zacks
CRISPR Therapeutics (CRSP) Q1 Earnings & Sales Miss Estimates
CRISPR Therapeutics (CRSP) reports wider-than-expected Q1 loss. Revenues miss estimates.
© 2022 Yahoo. All rights reserved.
